{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:34:25Z","timestamp":1789929265353,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.jpsychires.2008.06.001","type":"journal-article","created":{"date-parts":[[2008,7,22]],"date-time":"2008-07-22T08:40:40Z","timestamp":1216716040000},"page":"265-273","source":"Crossref","is-referenced-by-count":25,"title":["Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study"],"prefix":"10.1016","volume":"43","author":[{"given":"Josep Maria","family":"Haro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Novick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2008.06.001_bib1","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib2","unstructured":"American Psychiatric Association. Practice guidelines for the treatment of patients with schizophrenia (2nd ed.). American Journal of Psychiatry 2004;161 (Suppl. 2):1\u201356."},{"key":"10.1016\/j.jpsychires.2008.06.001_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-244X-6-8","article-title":"Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia","volume":"6","author":"Ascher-Svanum","year":"2006","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/JCP.0b013e3180582426","article-title":"All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics. An integrated analysis","volume":"27","author":"Beasley","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-9964(02)00431-0","article-title":"Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study","volume":"62","author":"Bobes","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/070674370505001404","article-title":"Ambulatory use of olanzapine and risperidone: a population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia","volume":"50","author":"Cooper","year":"2005","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/appi.ajp.158.5.765","article-title":"A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder","volume":"158","author":"Conley","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.schbul.a006920","article-title":"Antipsychotic prescribing practices in Connecticut\u2019s Public Mental Health System: rates of changing medications and prescribing styles","volume":"28","author":"Covell","year":"2002","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0149-2918(02)85018-4","article-title":"Dosing and switching strategies for quetiapine fumarate","volume":"24","author":"Cutler","year":"2002","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00023210-200216030-00007","article-title":"Spotlight on amisulpride in schizophrenia","volume":"16","author":"Curran","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpsyc.1995.03950150005001","article-title":"Neuroleptic withdrawal in schizophrenic patients. A review of the literature","volume":"52","author":"Gilbert","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib12","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.158.11.1835","article-title":"Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia","volume":"158","author":"Gitlin","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.schres.2006.06.021","article-title":"Olanzapine and haloperidol in first episode psychosis: two-year data","volume":"86","author":"Green","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib14","series-title":"ECDEU assessment manual for psychopharmacology, revised","article-title":"Clinical global impression","author":"Guy","year":"1976"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/070674379704200204","article-title":"Epidemiology of schizophrenia","volume":"42","author":"Hafner","year":"1997","journal-title":"Canadian Journal of Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2008.06.001_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0306-4530(02)00112-9","article-title":"Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"416","key":"10.1016\/j.jpsychires.2008.06.001_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","volume":"107","author":"Haro","year":"2003","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1034\/j.1600-0447.2003.00064.x","article-title":"The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment","volume":"107","author":"Haro","year":"2003","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00148365-200605010-00003","article-title":"Methodological aspects in the assessment of treatment effects in observational health outcome studies","volume":"5","author":"Haro","year":"2006","journal-title":"Applied Health Economics and Health Policy"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/01.jcp.0000246215.49271.b8","article-title":"Remission and relapse in the outpatient care of schizophrenia. Three-year results from the Schizohprenia Outpatient Health Outcomes Study","volume":"26","author":"Haro","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.euroneuro.2006.09.005","article-title":"Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results","volume":"17","author":"Haro","year":"2007","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.jcp.0000245563.06660.0f","article-title":"Differential rate of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia","volume":"26","author":"Kinon","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0447.2004.00451.x","article-title":"Olanzapine versus other antipsychotics in actual outpatient settings: 6-month safety results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study","volume":"111","author":"Lambert","year":"2005","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(98)00105-4","article-title":"Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials","volume":"35","author":"Leucht","year":"1999","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1176\/appi.ajp.164.7.1050","article-title":"Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison","volume":"164","author":"McEvoy","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/appi.ajp.162.3.495","article-title":"Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up","volume":"162","author":"Milev","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib28","unstructured":"National Institute for Clinical Excellence (NICE). Schizophrenia: full national clinical guideline on core interventions in primary and secondary care. London: NICE; 2002."},{"issue":"48","key":"10.1016\/j.jpsychires.2008.06.001_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1192\/bjp.187.48.s77","article-title":"Rational pharmacotherapy in early psychosis","volume":"187","author":"Remington","year":"2005","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2710.2006.00711.x","article-title":"Treatment persistence: a comparison among patients with schizophrenia who were initiated on atypical antipsychotic agents","volume":"31","author":"Ren","year":"2006","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder","volume":"56","author":"Robinson","year":"1999","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0920-9964(01)00312-7","article-title":"Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder","volume":"57","author":"Robinson","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","article-title":"Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder","volume":"161","author":"Robinson","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib34","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.162.5.947","article-title":"Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial","volume":"162","author":"Schooler","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00023210-200216010-00003","article-title":"Effects of newer antipsychotics on extrapyramidal function","volume":"16","author":"Tarsy","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bmj.38881.382755.2F","article-title":"Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation die to schizophrenia and schizoaffective disorder: observational follow-up study","volume":"333","author":"Tiihonen","year":"2006","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/ajp.154.4.457","article-title":"Olanzapine versus haloperidol in the treatment of schizophrenia, schizoaffective and schizophreniform disorders: results of an international collaboration study","volume":"154","author":"Tollefson","year":"1997","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1185\/030079907X162665","article-title":"An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia","volume":"23","author":"Tunis","year":"2007","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1176\/appi.ajp.159.1.133","article-title":"Elevation of prolactin levels by atypical antipsychotics","volume":"159","author":"Turrone","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.06.001_bib40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0022-3956(97)00014-9","article-title":"The effects of early and sustained intervention on the long-term morbidity of schizophrenia","volume":"32","author":"Wyatt","year":"1998","journal-title":"Journal of Psychiatric Research"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395608001349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395608001349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T08:18:39Z","timestamp":1684484319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395608001349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0022395608001349"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2008.06.001","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}